Mesoblast Ltd
Biotechnology
Healthcare
MESO
114 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
16.50
52 week high
21.04
high
16.57
52 week low
0.00
low
16.25
growth
138.10 %
previous Close
16.85
P/E ratio
market cap
1.54 B
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top